Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06239285 · ClinicalTrials.gov registry record · NA
A Virtual Reality Brief Violence Intervention: Preventing Gun Violence Among Violently Injured Adults
A NA study of Violence, sponsored by Virginia Commonwealth University.
- Recruiting
- Registry status
- NA
- Development phase
- 220
- Enrollment target
- 1
- Study location
NCT06239285: Recruiting NA study of Violence, sponsored by Virginia Commonwealth University.
NCT06239285 is a NA study of Violence that is actively recruiting participants, run by Virginia Commonwealth University. The registered enrollment target is 220 participants, below the 4,526-participant average among 19 other Violence trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06239285, a NA study of Violence, is actively recruiting participants, sponsored by Virginia Commonwealth University.
- RECRUITING
- Registry status
- NA
- Development phase
- 220 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall aim of the proposed project is to develop and evaluate the effectiveness of Brief Violence Intervention-Virtual Reality (BVI-VR) for reducing firearm-related violence, re-injury, and mortality among victims of violence. Outcome measures of firearm-related violence will come from multiple sources, including criminal background checks, hospital data, state-level data, semi-structured clinical assessments, and self-report assessments. In addition, the study aims to understand the impact of BVI-VR on psychosocial mediators resulting in a reduction of firearm-related violence. This will include self-report surveys, neurocognitive assessments, and clinical assessments. The economic efficiency of BVI-VR as a firearm-related violence intervention will also evaluated. To achieve these aims, a randomized control trial (RCT) in a large sample of violently injured adults (18+ years) from VCU Health will be conducted.
Primary Outcome
The gun violence questionnaire is a 9-item self-report that assesses firearm-related violence. Items were adapted from the Buss-Perry Aggression Questionnaire physical aggression scale; for example, "Given enough provocation, I may fire my gun at another person". The measure has adequate internal consistency (α = .75) and good convergent and discriminant validity with other violence related measures
Conditions Studied
Interventions
- OTHER Treatment as Usual (TAU)
- DEVICE Brief Violence Intervention VR (BVI-VR)
Study Locations (1)
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2024-02-26 |
| Est. Completion | 2026-10 |
| Phase | NA |
What NCT06239285 shows while recruiting
NCT06239285 is an interventional study that assigns participants to a tested intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap, below the 4,526-participant average among 19 other Violence trials with a reported enrollment target (95% lower).
The record links to 1 condition, with Violence appearing as the primary indexed condition, and to 2 interventions - of which Treatment as Usual (TAU) is the first listed.
NCT06239285 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT06239285 about?
NCT06239285 is a clinical study titled "A Virtual Reality Brief Violence Intervention: Preventing Gun Violence Among Violently Injured Adults". The overall aim of the proposed project is to develop and evaluate the effectiveness of Brief Violence Intervention-Virtual Reality (BVI-VR) for reducing firearm-related violence, re-injury, and mortality among victims of violence. Outcome measures of firearm-related violence will come from multiple...
What is the current status of trial NCT06239285?
This trial is currently recruiting. It is a NA study. The enrollment target is 220 participants. The study started on 2024-02-26. Estimated completion is 2026-10.
What conditions does trial NCT06239285 study?
This clinical trial studies the following conditions: Violence.
What interventions are being tested in trial NCT06239285?
The interventions under investigation include: Treatment as Usual (TAU) (OTHER), Brief Violence Intervention VR (BVI-VR) (DEVICE).
Who is sponsoring clinical trial NCT06239285?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06239285 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Violence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06239285's enrollment target sits among peer trials
220 18th of 19 higher than 2 of 19 other Violence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Violence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
An Evidence-based Family Support Program for Parents and Children in Palestine: a Theory-based Intervention
RECRUITING · NA
-
Preventing Retaliatory Gun Violence in Violently Injured Adults
RECRUITING · NA
-
#ChopViolence/#ChopHIV
RECRUITING · NA
-
A Hospital-based Intervention for Youth Injured Through Violence
RECRUITING · NA
-
Being Safe, Healthy, And Positively Empowered (BSHAPE) Intervention Study
RECRUITING · NA
-
Evaluation of California's Armed and Prohibited Persons System
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00920972 · 220 participants · Phase 1
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- NCT01851642 · 220 participants
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- NCT02582021 · 220 participants
WISE CVD - Continuation (WISE HFpEF)
- NCT04067830 · 220 participants · Phase 2
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI